Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 32 Breast Neoplasms 21 Neoplasms 16 Prostatic Neoplasms 11 Obesity 8 Sarcopenia 6 Colorectal Neoplasms 6 Pancreatic Neoplasms 5 Lung Neoplasms 5 Head and Neck Neoplasms 5 Polycystic Ovary Syndrome 4 Signs and Symptoms 3 Multiple Myeloma 3 Lymphedema 3 Inflammation 3 Fatigue 3 Diabetes Mellitus, Type 2 3 Colonic Neoplasms 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Pharyngeal Neoplasms 2 Overweight 2 Osteoporosis, Postmenopausal 2 Osteoporosis 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Laryngeal Neoplasms 2 Insulin Resistance 2 Hematopoietic and Lymphatic System Neoplasm 2

Interventions

Gemcitabine 13 Albumin-Bound Paclitaxel 8 Taxes 6 130-nm albumin-bound paclitaxel 6 Fluorouracil 5 Oxaliplatin 4 dehydroftorafur 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Leucovorin 3 Irinotecan 3 Losartan 2 Cisplatin 2 tocilizumab 1 selicrelumab 1 niraparib 1 irinotecan sucrosofate 1 indusatumab 1 folfirinox 1 durvalumab 1 cobimetinib 1 atezolizumab 1 X-Rays 1 Tiragolumab 1 Surgical Procedures, Operative 1 Standard of Care 1 Specimen Handling 1 S 1 (combination) 1 Resistance Training 1 Radiotherapy, Image-Guided 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreatic Adenocarcinoma × Resistance Training × Clear all

NCT02680990 2018-02-28

REACT

Milton S. Hershey Medical Center

Phase NA Completed

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡